Welcome to LookChem.com Sign In|Join Free
  • or
4-AMINO-5-(4-PYRIDYL)-4 H-1,2,4-TRIAZOLE-3-THIOL, also known as APPT, is a heterocyclic compound that features both a triazole and a thiol group. It is recognized for its diverse biological activities, such as antimicrobial, antiviral, and antitumor properties, and has been studied for its potential as an anti-inflammatory and antioxidant agent. The unique structure and functional groups of APPT make it a promising candidate for drug discovery and development in the pharmaceutical and agrochemical industries.

36209-51-5

Post Buying Request

36209-51-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

36209-51-5 Usage

Uses

Used in Pharmaceutical Industry:
4-AMINO-5-(4-PYRIDYL)-4 H-1,2,4-TRIAZOLE-3-THIOL is used as a building block for the synthesis of pharmaceuticals due to its diverse range of biological activities. It is particularly valued for its antimicrobial, antiviral, and antitumor properties, which make it a versatile component in the development of new drugs to combat various diseases.
Used in Agrochemical Industry:
In the agrochemical sector, 4-AMINO-5-(4-PYRIDYL)-4 H-1,2,4-TRIAZOLE-3-THIOL is utilized as a key component in the creation of agrochemicals. Its antimicrobial properties are harnessed to develop products that protect crops from diseases and pests, thereby enhancing agricultural productivity.
Used in Anti-Inflammatory Applications:
4-AMINO-5-(4-PYRIDYL)-4 H-1,2,4-TRIAZOLE-3-THIOL is used as an anti-inflammatory agent for its potential to modulate inflammatory responses. This application is crucial in the treatment of various inflammatory conditions and diseases.
Used in Antioxidant Formulations:
As an antioxidant agent, 4-AMINO-5-(4-PYRIDYL)-4 H-1,2,4-TRIAZOLE-3-THIOL is incorporated into formulations designed to combat oxidative stress and related conditions. Its role in neutralizing free radicals and protecting cells from damage makes it a valuable component in health and wellness products.

Check Digit Verification of cas no

The CAS Registry Mumber 36209-51-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,2,0 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 36209-51:
(7*3)+(6*6)+(5*2)+(4*0)+(3*9)+(2*5)+(1*1)=105
105 % 10 = 5
So 36209-51-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H7N5S/c8-12-6(10-11-7(12)13)5-1-3-9-4-2-5/h1-4H,8H2,(H,11,13)

36209-51-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (438545)  4-Amino-5-(4-pyridyl)-4H-1,2,4-triazole-3-thiol  97%

  • 36209-51-5

  • 438545-1G

  • 441.09CNY

  • Detail

36209-51-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-amino-3-pyridin-4-yl-1H-1,2,4-triazole-5-thione

1.2 Other means of identification

Product number -
Other names 4-amino-5-(4-pyridyl)-1,2,4-triazole-3-thiol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:36209-51-5 SDS

36209-51-5Synthetic route

pyridine-4-carboxylic acid
55-22-1

pyridine-4-carboxylic acid

Thiocarbohydrazide
2231-57-4

Thiocarbohydrazide

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Heating;96%
potassium 4-pyridinyldithiocarbazate
61019-32-7

potassium 4-pyridinyldithiocarbazate

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
With hydrazine hydrate at 140 - 160℃; for 6h;80%
With hydrazine hydrate In water for 3h; Reflux;80%
With hydrazine hydrate In water Heating;78%
carbon disulfide
75-15-0

carbon disulfide

isoniazid
54-85-3

isoniazid

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Stage #1: isoniazid With potassium hydroxide In methanol at 0 - 5℃;
Stage #2: carbon disulfide In methanol at 0 - 20℃;
Stage #3: With hydrazine hydrate In water Reflux;
80%
Stage #1: carbon disulfide; isoniazid With potassium hydroxide In ethanol at 20℃; for 12h;
Stage #2: With hydrazine hydrate In water for 6h; Reflux;
Stage #3: With hydrogenchloride In water Cooling;
72%
Stage #1: carbon disulfide; isoniazid With potassium hydroxide In ethanol at 20℃;
Stage #2: With hydrazine In water for 6h; Reflux;
72%
5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol
15264-63-8

5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
With hydrazine hydrate for 0.133333h; microwave irradiation;70%
With hydrazine hydrate
Stage #1: 5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol With hydrazine hydrate at 20℃; for 2h;
Stage #2: for 4h; Reflux;
Stage #3: With hydrogenchloride
With hydrazine hydrate In ethanol Reflux;
With pyridine; hydrazine hydrate at 120℃; for 12h;
potassium 2-isonicotinoyl hydrazine carbothionate

potassium 2-isonicotinoyl hydrazine carbothionate

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
With hydrazine hydrate In water for 8h; Reflux;62%
With hydrazine hydrate In water for 1h; Heating; Yield given;
C7H6N3OS2(1-)*K(1+)

C7H6N3OS2(1-)*K(1+)

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
With hydrazine hydrate In water Heating;
isoniazid
54-85-3

isoniazid

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: KOH / ethanol / 14 h
2: hydrazine hydrate / H2O / Heating
View Scheme
Multi-step reaction with 2 steps
1: KOH / ethanol
2: 52 percent / N2H4 / H2O / 2 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: carbon disulphide, potassium hydroxide / ethanol
2: 80 percent / 80percent hydrazine / 6 h / 140 - 160 °C
View Scheme
pyridine-4-carboxylic acid
55-22-1

pyridine-4-carboxylic acid

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: H2SO4
2.1: H2NNH2*H2O
3.1: KOH
3.2: H2NNH2*H2O / 120 °C
View Scheme
Multi-step reaction with 4 steps
1.1: sulfuric acid / Reflux
2.1: hydrazine hydrate / Reflux
3.1: potassium hydroxide / methanol / 0.25 h
3.2: 3 h / 20 - 25 °C
4.1: hydrazine hydrate / water / 1 h / Reflux
View Scheme
Multi-step reaction with 4 steps
1.1: sulfuric acid / Reflux
2.1: hydrazine hydrate / methanol / 0.03 h / Microwave irradiation
3.1: potassium hydroxide / methanol / 0 - 5 °C
4.1: hydrazine hydrate / 0.03 h / Microwave irradiation
4.2: 0.03 h
View Scheme
isonicotinic acid ethylester
1570-45-2

isonicotinic acid ethylester

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: H2NNH2*H2O
2.1: KOH
2.2: H2NNH2*H2O / 120 °C
View Scheme
Multi-step reaction with 3 steps
1: hydrazine hydrate / ethanol / Reflux
2: potassium hydroxide / ethanol
3: hydrazine hydrate / water / Heating
View Scheme
Multi-step reaction with 3 steps
1.1: hydrazine hydrate / methanol / 0.03 h / Microwave irradiation
2.1: potassium hydroxide / methanol / 0 - 5 °C
3.1: hydrazine hydrate / 0.03 h / Microwave irradiation
3.2: 0.03 h
View Scheme
Multi-step reaction with 3 steps
1: hydrazine hydrate / ethanol / 24 h / Reflux
2: potassium hydroxide / ethanol / 12 h / 20 °C / Cooling with ice
3: hydrazine hydrate / water / 24 h / Reflux
View Scheme
isoniazid
54-85-3

isoniazid

O2,O4;O3,O5-<(R,S)-dibenzylidene>-D-xylose

O2,O4;O3,O5-<(R,S)-dibenzylidene>-D-xylose

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium hydroxide / ethanol / 3 h / 25 °C
2: hydrazine hydrate / H2O / 1 h / Heating
View Scheme
4-pyridinecarboxylic acid, methyl ester
2459-09-8

4-pyridinecarboxylic acid, methyl ester

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: hydrazine hydrate / Reflux
2.1: potassium hydroxide / methanol / 0.25 h
2.2: 3 h / 20 - 25 °C
3.1: hydrazine hydrate / water / 1 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: hydrazine / ethanol
2: potassium hydroxide
3: hydrazine hydrate / 5 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: hydrazine hydrate / 6 h / Reflux
2: potassium hydroxide / Reflux
3: hydrazine hydrate / 5 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: hydrazine hydrate / 14 h / Reflux
2: potassium hydroxide / ethanol / 20 °C
3: hydrazine hydrate / 10 h / Reflux
View Scheme
1-isonicotinoyl-1H-imidazole
90322-87-5

1-isonicotinoyl-1H-imidazole

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / tetrahydrofuran / 20 °C
2: potassium hydroxide / ethanol / 20 °C
3: hydrazine hydrate / water / 20 °C / Reflux
View Scheme
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

benzoyl chloride
98-88-4

benzoyl chloride

4-(pyridine-4-yl)-7-phenyl-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole
133847-07-1

4-(pyridine-4-yl)-7-phenyl-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;100%
With trichlorophosphate for 8h; Heating;70%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Hexanoyl chloride
142-61-0

Hexanoyl chloride

6-Pentyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
135586-36-6

6-Pentyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;100%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

n-decanoyl chloride
112-13-0

n-decanoyl chloride

6-Nonyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
140842-00-8

6-Nonyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;100%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

2-Bromo-4'-methoxyacetophenone
2632-13-5

2-Bromo-4'-methoxyacetophenone

6-(4-methoxyphenyl)-3-(pyridin-4-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine

6-(4-methoxyphenyl)-3-(pyridin-4-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine

Conditions
ConditionsYield
In ethanol at 95℃; for 0.5h; Microwave irradiation;99%
Stage #1: 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol; 2-Bromo-4'-methoxyacetophenone In ethanol for 2h; Reflux;
Stage #2: With ammonium hydroxide In ethanol at 20℃;
78%
In ethanol for 24h; Heating;62%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Nonanoyl chloride
764-85-2

Nonanoyl chloride

6-Octyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
140841-99-2

6-Octyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;98%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

acetyl chloride
75-36-5

acetyl chloride

6-methyl-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
135586-33-3

6-methyl-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;98%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

isobutyryl chloride
79-30-1

isobutyryl chloride

6-Isopropyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
135586-35-5

6-Isopropyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;96%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

butyryl chloride
141-75-3

butyryl chloride

6-Propyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
135586-34-4

6-Propyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;96%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

Heptanoic acid chloride
2528-61-2

Heptanoic acid chloride

6-Hexyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
135586-37-7

6-Hexyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;96%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

n-octanoic acid chloride
111-64-8

n-octanoic acid chloride

6-Heptyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
140841-98-1

6-Heptyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;96%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

4-Chlorophenoxyacetic acid
122-88-3

4-Chlorophenoxyacetic acid

6-((4-chlorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
133847-09-3

6-((4-chlorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;96%
With trichlorophosphate for 1.5h; Reflux;90%
With trichlorophosphate for 1.5h; Reflux;90%
(2-naphthoyl)oxyacetic acid
120-23-0

(2-naphthoyl)oxyacetic acid

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

6-((2-naphthyloxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

6-((2-naphthyloxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;96%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

(E)-1-(furan-2-yl)-3-(4-methoxyphenyl)-2-propen-1-one
137444-58-7

(E)-1-(furan-2-yl)-3-(4-methoxyphenyl)-2-propen-1-one

8-(2-furyl)-5,6-dihydro-6-(4-methoxyphenyl)-3-(pyridin-4-yl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazepine

8-(2-furyl)-5,6-dihydro-6-(4-methoxyphenyl)-3-(pyridin-4-yl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazepine

Conditions
ConditionsYield
With aluminum oxide for 0.0833333h; microwave irradiation;95%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

acetic acid
64-19-7

acetic acid

6-methyl-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
135586-33-3

6-methyl-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Reflux;95%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

2-(4-methoxyphenoxy)acetic acid
1877-75-4

2-(4-methoxyphenoxy)acetic acid

6-((4-methoxyphenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
1438398-32-3

6-((4-methoxyphenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;95%
With trichlorophosphate Reflux;76%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

m-tolyl aldehyde
620-23-5

m-tolyl aldehyde

4-(3-methylbenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

4-(3-methylbenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.0166667h; Microwave irradiation;94.92%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

meta-hydroxybenzaldehyde
100-83-4

meta-hydroxybenzaldehyde

4-[{1-(3'-hydroxyphenyl)methylidine}amino]-3-(4-pyridyl)-5-mercapto-4H-1,2,4-triazole
497942-65-1

4-[{1-(3'-hydroxyphenyl)methylidine}amino]-3-(4-pyridyl)-5-mercapto-4H-1,2,4-triazole

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.025h; Microwave irradiation;94.28%
With acetic acid In N,N-dimethyl-formamide for 9h; Reflux;62%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

isopentanoyl chloride
108-12-3

isopentanoyl chloride

6-Isobutyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
140842-01-9

6-Isobutyl-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With trichlorophosphate for 5h; Heating;94%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

4-nitrophenoxyacetic acid
1798-11-4

4-nitrophenoxyacetic acid

6-((4-nitrophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
478362-97-9

6-((4-nitrophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;94%
With trichlorophosphate for 1.5h; Reflux;85%
With trichlorophosphate for 1.5h; Reflux;85%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

2-(4-fluorophenoxy)ethanoic acid
405-79-8

2-(4-fluorophenoxy)ethanoic acid

6-((4-fluorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
791824-11-8

6-((4-fluorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;94%
With trichlorophosphate Reflux;79%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

1-isothiocyanato-4-methylbenzene
622-59-3

1-isothiocyanato-4-methylbenzene

N-(4-methylphenyl)-3-(pyridin-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine

N-(4-methylphenyl)-3-(pyridin-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine

Conditions
ConditionsYield
With pyridine Reflux;94%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

4-Bromophenyl isothiocyanate
1985-12-2

4-Bromophenyl isothiocyanate

1-(4-bromophenyl)-3-(3-mercapto-5-(pyridin-4-yl)-4H-1,2,4-triazol-4-yl)thiourea

1-(4-bromophenyl)-3-(3-mercapto-5-(pyridin-4-yl)-4H-1,2,4-triazol-4-yl)thiourea

Conditions
ConditionsYield
With pyridine for 0.5h; Reflux;94%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

4-fluorobenzaldehyde
459-57-4

4-fluorobenzaldehyde

4-(4-fluorobenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

4-(4-fluorobenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.0166667h; Microwave irradiation;93.65%
In methanol Reflux;71%
(4-bromophenoxy)acetic acid
1878-91-7

(4-bromophenoxy)acetic acid

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

6-((4-bromophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

6-((4-bromophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;93%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

MCPA
94-74-6

MCPA

6-((2-methyl-4-chlorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

6-((2-methyl-4-chlorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

Conditions
ConditionsYield
With dmap; tetrabutylammomium bromide; trichlorophosphate Microwave irradiation; Heating;93%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

4-Carboxybenzaldehyde
619-66-9

4-Carboxybenzaldehyde

4-(4-carboxylbenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

4-(4-carboxylbenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.0166667h; Microwave irradiation;92.31%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

4-nitrobenzaldehdye
555-16-8

4-nitrobenzaldehdye

4-(4-nitrobenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole
497864-69-4

4-(4-nitrobenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.025h; Microwave irradiation;92.02%
With sulfuric acid In ethanol Reflux;85%
With acetic acid for 3h; Reflux;85%
In methanol Reflux;79%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

2-nitro-benzaldehyde
552-89-6

2-nitro-benzaldehyde

4-(2-nitrobenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole
497231-69-3

4-(2-nitrobenzylideneamino)-3-mercapto-5-pyridin-4-yl-4H-1,2,4-triazole

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.0166667h; Microwave irradiation;92.02%
With acetic acid for 3h; Reflux;85%
4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol
36209-51-5

4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol

bromocyane
506-68-3

bromocyane

3-(4-pyridyl)-6-amino-s-triazolo<3,4-b>-1,3,4-thiadiazole
80809-41-2

3-(4-pyridyl)-6-amino-s-triazolo<3,4-b>-1,3,4-thiadiazole

Conditions
ConditionsYield
In ethanol Heating;92%

36209-51-5Relevant academic research and scientific papers

Exploiting the Role of Molecular Electrostatic Potential, Deformation Density, Topology, and Energetics in the Characterization of S?N and Cl?N Supramolecular Motifs in Crystalline Triazolothiadiazoles

Khan, Imtiaz,Panini, Piyush,Khan, Salah Ud-Din,Rana, Usman Ali,Andleeb, Hina,Chopra, Deepak,Hameed, Shahid,Simpson, Jim

, p. 1371 - 1386 (2016)

A detailed analysis of the molecular and crystal packing of a series of pharmaceutically active triazolothiadiazole derivatives is reported. The most notable feature from the analysis of the supramolecular motifs is the presence of inversion dimers due to the formation of strong S?N chalcogen bonds. This has been unequivocally established via inputs from energy calculations from PIXEL, the topological analysis using the approach of QTAIM from AIMALL, an analysis of the molecular electrostatic potentials plotted on Hirshfeld surfaces, and the analysis of the 3D-deformation densities obtained using Crystal Explorer. The total interaction energy for this contact is in the range of 28-33 kJ/mol in the molecules under investigation, and the electrostatic (Coulombic + polarization) contribution toward the total stabilization energy is more than 70%, indicating that such interactions are principally electrostatic in origin. The results from the analysis of the molecular ESP depict that this interaction exists between a strongly electropositive σ-hole on the sulfur atom and an electronegative region on the nitrogen. 3D-deformation density (DD) maps reveal the presence of a charge depletion (CD) region on the sulfur atom which is directed toward the charge concentration (CC) region on the nitrogen atom facilitating formation of such contacts in the crystal. These are further invesigated by QTAIM based calculations which establish the closed-shell nature of these contacts. The crystal packing is further stabilized by the presence of significantly important π?π stacking interactions, wherein the interaction energies, calculated by the PIXEL method, reveal that some of these interactions in crystals have significant contributions from electrostatic components, with a lesser contribution from dispersion forces that normally dominate such interactions. The existence of a contribution of ~48% from electrostatics between stacked rings owing to their unique electrostatic complementarity is a rare supramolecular feature observed in crystal packing in these solids. In addition, the existence of C-H?O, C-H?N, C-H?F, and Cl?N interactions is also characterized by a significant electrostatic component in their formation in crystals of these compounds.

Synthesis, crystal structures, molecular docking and urease inhibitory activity of nickel(II) complexes with 3-pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Xu, Yong-Peng,Qin, Jie,Sun, Shi-Min,Liu, Tong-Tong,Zhang, Xiao-Lin,Qian, Shao-Song,Zhu, Hai-Liang

, p. 469 - 476 (2014)

Three novel complexes, [NiII(dpp)2(L)2] (1), [NiII(eda)2(L)2] (2) and [NiII(deda)2(L)2] (3) (L = 3-pyridinyl-4-amino-5-mercapto-1,2,4-triazole, dpp = 1,3-di

Synthesis of some new acylhydrazone compounds containing the 1,2,4-triazole structure and their neuritogenic activities in Neuro-2a cells

Jiang, Xia,Tang, Genyun,Yang, Jie,Ding, Jiacheng,Lin, Hongwei,Xiang, Xiaoliang

, p. 18927 - 18935 (2020)

In the present study, a novel series of acylhydrazone compounds (A0-A10) with the structure of 1,2,4-triazole have been designed and synthesized. In addition, all the synthesized compounds have been evaluated for neuritogenic activity in mouse neuroblastoma (Neuro-2a) cells. Notably, we found that one of these 11 acylhydrazone compounds, compoundA5(2-(4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-ylthio)-N′-(2-hydroxybenzylidene)-acetohydrazide) displays excellent neuritogenic activity. Moreover, our present study revealed that compoundA5had the ability to induce neurite outgrowth through the PI3K/Akt and MEK-ERK signaling pathway in Neuro-2a cells. These findings suggest that compoundA5might exert neuritogenic effects and thus may be useful for the treatment of neural repair and regeneration.

Synthesis, crystal structures, molecular docking, and urease inhibitory activities of transition-metal complexes with a 1,2,4-triazolecarboxylic acid derived ligand

Xu, Yong-Peng,Chen, Yue-Hu,Chen, Zhi-Jian,Qin, Jie,Qian, Shao-Song,Zhu, Hai-Liang

, p. 2076 - 2084 (2015)

Four novel complexes, [Cu(L)2(NH3)2(H2O)2] (1), {[Cu(L)2(H2O)2]·2H2O}n (2), {[Zn(L)2(H2O)2]·2H2O}n (3), and {[Fe(L)2(H2O)2]·2H2O}n (4) (HL = 2-{[4-amino-3-(pyridin-4-yl)-4,5-dihydro-1H-1,2,4-triazol-5-yl]thio}acetic acid) were synthesized and characterized by single-crystal X-ray diffraction analysis. Complex 1 exhibited a mononuclear structure. Complexes 2, 3, and 4 featured 2D networks. The crystal structures were stabilized by intermolecular hydrogen bonds to generate 3D supramolecular frameworks. The inhibitory activity was tested in vitro against jack bean urease. Among the four complexes, the two CuII complexes 1 and 2 exhibited better inhibitory activity than the positive reference acetohydroxamic acid, with IC50 values of 4.052 and 6.868 μM, respectively, whereas the ZnII and FeII complexes showed no activity. To explore the mechanism of inhibition of the enzyme, kinetics studies were carried out; the results indicated that both the activated complexes 1 and 2 operated through a mixed-competitive inhibitory mechanism. Molecular docking was used to insert the most active complex 1 into the crystal structure of jack bean urease at the active site to determine the probable mode of binding. Four novel crystals of copper, zinc, and iron complexes based on 1,2,4-triazole carboxylic acid derivatives were determined by single-crystal X-ray diffraction. The inhibitory activity and kinetic studies were tested in vitro against jack bean urease. The computational predications, biological evaluation, and mechanism study will help in the discovery of new urease inhibitors.

HERBICIDAL COMPOUNDS

-

Page/Page column 88-89, (2021/04/10)

Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors

Baud, Damien,Bebrone, Carine,Becker, Katja,Benvenuti, Manuela,Cerboni, Giulia,Chelini, Giulia,Cutolo, Giuliano,De Luca, Filomena,Docquier, Jean-Denis,Feller, Georges,Fischer, Marina,Galleni, Moreno,Gavara, Laurent,Gresh, Nohad,Kwapien, Karolina,Legru, Alice,Mangani, Stefano,Mercuri, Paola,Pozzi, Cecilia,Sannio, Filomena,Sevaille, Laurent,Tanfoni, Silvia,Verdirosa, Federica,Berthomieu, Dorothée,Bestgen, Beno?t,Frère, Jean-Marie,Hernandez, Jean-Fran?ois

supporting information, (2020/09/16)

Resistance to β-lactam antibiotics in Gram-negatives producing metallo-β-lactamases (MBLs) represents a major medical threat and there is an extremely urgent need to develop clinically useful inhibitors. We previously reported the original binding mode of 5-substituted-4-amino/H-1,2,4-triazole-3-thione compounds in the catalytic site of an MBL. Moreover, we showed that, although moderately potent, they represented a promising basis for the development of broad-spectrum MBL inhibitors. Here, we synthesized and characterized a large number of 4-amino-1,2,4-triazole-3-thione-derived Schiff bases. Compared to the previous series, the presence of an aryl moiety at position 4 afforded an average 10-fold increase in potency. Among 90 synthetic compounds, more than half inhibited at least one of the six tested MBLs (L1, VIM-4, VIM-2, NDM-1, IMP-1, CphA) with Ki values in the μM to sub-μM range. Several were broad-spectrum inhibitors, also inhibiting the most clinically relevant VIM-2 and NDM-1. Active compounds generally contained halogenated, bicyclic aryl or phenolic moieties at position 5, and one substituent among o-benzoic, 2,4-dihydroxyphenyl, p-benzyloxyphenyl or 3-(m-benzoyl)-phenyl at position 4. The crystallographic structure of VIM-2 in complex with an inhibitor showed the expected binding between the triazole-thione moiety and the dinuclear centre and also revealed a network of interactions involving Phe61, Tyr67, Trp87 and the conserved Asn233. Microbiological analysis suggested that the potentiation activity of the compounds was limited by poor outer membrane penetration or efflux. This was supported by the ability of one compound to restore the susceptibility of an NDM-1-producing E. coli clinical strain toward several β-lactams in the presence only of a sub-inhibitory concentration of colistin, a permeabilizing agent. Finally, some compounds were tested against the structurally similar di-zinc human glyoxalase II and found weaker inhibitors of the latter enzyme, thus showing a promising selectivity towards MBLs.

Design, synthesis, biological activity, crystal structure and theoretical calculations of novel 1,2,4-triazole derivatives

Jin, Ruyi,Wang, Yanyan,Guo, Hui,Long, Xu,Li, Jiajia,Yue, Shijun,Zhang, Shuan,Zhang, Guanghui,Meng, Qinghua,Wang, Chuan,Yan, Hao,Tang, Yuping,Zhou, Sha

, (2019/10/28)

Series of 1,2,4-triazole Schiff base (Ia-f) were designed and synthesized. Their in-vitro antifungal activity to pythium solani, gibberlla nicotiancola, fusarium oxysporium fs.p. niveum and gibberlla saubinetii were evaluated. The results showed compound If exhibited good activity with tested fungi, which indicated that 1,2,4-triazole scaffold with introduction of imidazole phenyl could keep the antifungal activity. In order to further research the compound If, the crystal structure was detected by X-ray diffraction. Meanwhile, the FT-IR, FT-Raman, natural bond orbital (NBO), HOMO-LUMO and MEP were calculated at B3LYP/6-311G+(d,p) level. All the results will be helpful for further drug design in 1,2,4-triazole analogues.

Acylhydrazone compound and preparation method and application thereof

-

Paragraph 0079; 0084-0086, (2019/04/02)

The invention relates to an acylhydrazone compound and a preparation method and the application thereof. The acylhydrazone compound has the following structure as shown in a formula, wherein, R is selected from one of the two parts of the formula. The acylhydrazone compound can promote neural cell differentiation and neurite growth.

Synthesis, characterisation of new derivatives with mono ring system of 1,2,4-triazole scaffold and their anticancer activities

Slaihim, Mukhlif Mohsin,Al-Suede, Fouad Saleih R.,Khairuddean, Melati,Khadeer Ahamed, Mohamed B.,Shah Abdul Majid, Amin Malik

, p. 78 - 87 (2019/06/27)

In the present study, two important starting materials and 18 new 1,2,4-triazole compounds with mono ring system have been synthesized and characterized. The mono system showed 16 compounds of a Schiff base moiety attached to the triazole ring which was prepared from the corresponding starting material 5(A–B) or piperidinium salt system 6(A–B). All these compounds were characterized using Fourier Transform Infrared (FT-IR) and Nuclear Magnetic Resonance (NMR) spectroscopy and carbon hydrogen nitrogen (CHN) elemental analysis. The compounds were selected for in vitro anticancer study to test the therapeutic cytotoxic potential against cancer cells. The MTT test was conducted against human breast (MCF-7) and colorectal (HCT-116) cancer cells. Among all the compounds tested, 7A-i demonstrated more pronounced in vitro anticancer effect against MCF-7 and HCT-116 cells with IC50 of 38 and 19.2 μM, respectively, comparable to that of the standard reference drugs, tamoxifen and 5-fluorouracil, respectively. Compound 7A-vi showed a considerable cytotoxic effect with IC50 53 and 41.2 μM against MCF-7 and HCT-116 cells, respectively. Compounds 7A-ii, 7A-iii and 7A-v exhibited moderate cytotoxicity with IC50 68, 91 and 85 μM, respectively against MCF-7 cells and also 59.3, 81.7 and 137.1 μM against HCT-116 cells, respectively. However, all other compounds tested in this study showed poor cytotoxicity against both the cell lines. Cellular morphological analysis revealed that the cytotoxicity induced by the compounds could probably due to autophagy. It can be concluded that 1,2,4-triazole derivatives can be promising therapeutic agents. Further studies will be done to investigate the antitumor efficacy of the 1,2,4-triazole derivatives using suitable preclinical models.

Design, synthesis, characterization and antitubercular screening of some new 1,2,4-triazoles derived from isonicotinic acid hydrazides

Rajoriya, Vaibhav,Kashaw, Varsha,Kashaw, Sushil K.

, p. 451 - 462 (2018/06/19)

Background: A new series of substituted 1,2,4-triazoles derivative were synthesized and characterized by IR,1 HNMR,13 CNMR spectra, mass spectroscopy and elemental analysis. Methods: The isonicotinic acid hydrazide (INH) was used as starting material. These synthesized compounds were screened for antitubercular activities by Luciferase Reporter Phase (LRP) assay against drug sensitive reference strain (H37 RV) and on S, H, R & E resistant M. tuberculosis (MDR) clinical isolate. First line drug Rifampicin and Isoniazid were used as standard drugs. Result: The study revealed that all the screened compounds showed good to moderate activity except compounds 5b & 5q. Conclusion: The antitubercular activity indicated that the substitution of groups at third and fourth position of 1,2,4-triazole potentiate the activity as compare to isoniazid and rifampicin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 36209-51-5